NDC 51662-1555 – Hyaluronidase

Hyaluronidase (human Recombinant) 150 [USP'U]/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC51662-1555

Product details

Brand name
Hyaluronidase
Generic name
Hyaluronidase
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA021859
Marketed since
June 4, 2021
Listing expires
December 31, 2026
Pharmacologic class
Endoglycosidase

Active ingredients

Uses, dosage, side effects and warnings for Hyaluronidase →

Package NDC codes (1)

Package NDCDescriptionSince
51662-1555-11 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIALJun 4, 2021